中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

43 records (took 0.028 seconds)

    Amino acid derivatives for peptide synthesis
    2.
    发明授权
    Amino acid derivatives for peptide synthesis 失效
    用于肽合成的氨基酸衍生物

    公开(公告)号：US5455363A

    公开(公告)日：1995-10-03

    申请号：US957677

    申请日：1992-10-07

    Applicant: Jacques Gosteli ,  Beat Sax ,  Fritz Dick ,  Rudolf Tanner

    Inventor： Jacques Gosteli ,  Beat Sax ,  Fritz Dick ,  Rudolf Tanner

    IPC: C07C237/06 ,  C07C271/22 ,  C07K1/06 ,  C07K7/04

    CPC classification number: C07C237/06 ,  C07C271/22 ,  C07K1/066 ,  C07C2103/18 ,  Y02P20/55

    Abstract: Compounds of formula I are described, ##STR1## wherein n is equal to one or two, R.sub.1 stands for hydrogen or an amino protecting group, R.sub.2 represents hydrogen or a carboxyl protecting group and R.sub.3 4-methyltriphenylmethyl, 4,4'-dimethyltriphenylmethyl, 4,4',4"-trimethyltriphenylmethyl. Furthermore described are compounds of formula I which are reactive and suitable for coupling reactions and are derived from I with R.sub.2 =H by activation of the carboxyl group.The compounds mentioned above can be used as starting materials for the synthesis of peptides. They are more suitable than analogous compounds of formula I, wherein R.sub.3 represents hydrogen or a carbamoyl protecting group used hitherto.

    Abstract translation: 描述式I化合物，其中n等于1或2，R1代表氢或氨基保护基，R2代表氢或羧基保护基，R3,4-甲基三苯基甲基，4,4'-二甲基三苯基甲基 ，4,4'，4“ - 三甲基三苯基甲基。 此外还描述了反应性和适用于偶联反应的式I化合物，并且通过活化羧基得到R 2 = H的I化合物。 上述化合物可以用作合成肽的起始原料。 它们比类似式I化合物更合适，其中R 3表示氢或迄今使用的氨基甲酰基保护基。

    Process for preparing thia-aza compounds with a beta-lactam ring
    3.
    发明授权
    Process for preparing thia-aza compounds with a beta-lactam ring 失效
    用β-内酰胺环制备噻唑化合物的方法

    公开(公告)号：US4500457A

    公开(公告)日：1985-02-19

    申请号：US353288

    申请日：1982-03-01

    Applicant: Jacques Gosteli ,  Ivan Ernest ,  Robert B. Woodward

    Inventor： Jacques Gosteli ,  Ivan Ernest ,  Robert B. Woodward

    IPC: C07D205/09 ,  C07D499/88 ,  C07F9/568 ,  C07D501/02

    CPC classification number: C07F9/5683 ,  C07D205/09 ,  C07D499/88

    Abstract: 2-Penem-3-carboxylic acid compounds of the formula ##STR1## in which R.sub.1 represents hydrogen, an organic radical bonded by a carbon atom to the ring carbon atom or an etherified mercapto group andR.sub.2 represents hydroxy or a radical R.sub.2.sup.A forming together with the carbonyl grouping --C(.dbd.O)-- a protected carboxyl group,1-oxides thereof, as well as salts of such compounds having salt-forming groups, in racemic and optically active form, processes for their preparation, pharmaceutical compositions containing such compounds, and their use as antibiotics, and intermediates and their processes which are useful in the production of the compounds of the formula I.

    Abstract translation: 其中R 1表示氢，通过碳原子键合到环碳原子上的有机基团或醚化的巯基，R 2表示羟基或基团R 2 A的2-蒎烯-3-羧酸化合物 与羰基-C（= O） - 被保护的羧基，其1-氧化物以及具有成盐基团的化合物的盐以外消旋和旋光形式一起形成，其制备方法，药物组合物 含有这些化合物及其作为抗生素的用途，以及可用于制备式I化合物的中间体及其方法。

    Process for the preparation of 5-substituted resorcinols and related intermediates
    5.
    发明授权
    Process for the preparation of 5-substituted resorcinols and related intermediates 失效
    5-取代的间苯二酚和相关中间体的制备方法

    公开(公告)号：US4249027A

    公开(公告)日：1981-02-03

    申请号：US737377

    申请日：1976-11-01

    Applicant: Jacques Gosteli

    Inventor： Jacques Gosteli

    IPC: C07C69/88 ,  C07C37/50 ,  C07C39/08 ,  C07C51/09 ,  C07C39/12

    CPC classification number: C07C51/09 ,  C07C37/50

    Abstract: According to the present invention, 5-substituted resorcinols of the formula I ##STR1## wherein R.sub.1 represents a hydrocarbon radical, optionally unsubstituted or substituted by inert substituents, are prepared by reacting a carboxylic acid ester of the formula IIR.sub.1 --C.tbd.C--CO--O--R.sub.2 (II)wherein R.sub.2 represents a non-aromatically bound lower hydrocarbon radical, in the presence of an alkaline condensation agent, with a diester of 3-oxoglutaric acid of the formula IIIR.sub.3 --O--CO--CH.sub.2 --CO--CH.sub.2 --CO--O--R.sub.4 (III)wherein R.sub.3 and R.sub.4 represent non-aromatically bound lower hydrocarbon radicals; hydrolyzing the resulting dihydroxyisophthalic acid acid ester of the formula IV ##STR2## and decarboxylating the hydrolyzed product, a specific embodiment is the preparation of 5-pentylresorcinol.

    Abstract translation: 根据本发明，式I的5-取代的间苯二酚（I）其中R 1表示任选未被取代或被惰性取代基取代的烃基，通过使式II的羧酸酯R1-C 其中R 2表示非芳香结合的低级烃基，在碱性缩合剂的存在下，与式III的3-氧代戊二酸的二酯R 3 -O-CO- CH2-CO-CH2-CO-O-R4（Ⅲ）其中R3和R4代表非芳香结合的低级烃基; 水解所得的式IV（IV）的二羟基间苯二酸酸酯并使水解产物脱羧，具体实施方案是5-戊基间苯二酚的制备。

    Process for the manufacture of indigoid dyes
    6.
    发明授权
    Process for the manufacture of indigoid dyes 失效
    靛蓝染料的制造方法

    公开(公告)号：US4151170A

    公开(公告)日：1979-04-24

    申请号：US751223

    申请日：1976-12-16

    Applicant: Jacques Gosteli

    Inventor： Jacques Gosteli

    IPC: C09B7/00 ,  C07C67/00 ,  C07C201/00 ,  C07C205/45 ,  C09B7/02 ,  D06P1/28 ,  D06P3/60

    CPC classification number: C09B7/02

    Abstract: A process for the manufacture of indigoid dyes, wherein a functional derivative of the anthranilic acid of the general formula I ##STR1## in which A completes a mono- or polynuclear, substituted or unsubstituted aromatic ring,X represents a hydrogen atom or a protective group for the free amino group which can form an anhydro derivative with the carboxyl group in the ortho-position,Is reacted with nitromethane in the presence of a base or with a salt of nitroacetic acid to give the .omega.-nitro-o-amino-acetophenone derivative of the general formula II ##STR2## in which A and X are as defined in formula I, and this intermediate is condensed by heating with acids to give the indigo compound of the general formula III ##STR3## in which A is as defined in formula I.

    Abstract translation: 靛蓝染料的制备方法，其中通式Ⅰ的邻氨基苯甲酸的功能性衍生物（I）其中A完成单或多核，取代或未取代的芳环，X表示氢原子或 可以在邻位形成具有羧基的脱水衍生物的游离氨基的保护基，在碱存在或与硝酸盐存在下与硝基甲苯反应以产生ω-NITRO-O- 其中A和X如式I所定义的通式II（II）的氨基 - 乙炔酮衍生物，并且该中间体通过与酸加热而缩合，得到通式III的靛蓝化合物（IMAGE）（ III）其中A如式I所定义。

    2-Penem compounds
    7.
    发明授权
    2-Penem compounds 失效
    2-Penem化合物

    公开(公告)号：US4070477A

    公开(公告)日：1978-01-24

    申请号：US746979

    申请日：1976-12-02

    Applicant: Ivan Ernest ,  Jacques Gosteli ,  Robert Burns Woodward

    Inventor： Ivan Ernest ,  Jacques Gosteli ,  Robert Burns Woodward

    IPC: C07D499/04 ,  A61K31/397 ,  A61K31/43 ,  A61P31/04 ,  C07D205/08 ,  C07D205/095 ,  C07D403/04 ,  C07D499/21 ,  C07D499/44 ,  C07D499/88 ,  C07F9/568 ,  A61K31/425 ,  C07D499/02

    CPC classification number: C07D499/88 ,  C07D205/095 ,  C07F9/5683 ,  Y02P20/55

    Abstract: The invention relates to 6-amino-2-penem-3-carboxylic acid compounds of the formula ##STR1## in which R.sub.1.sup.a denotes hydrogen or an amino protective group R.sub.1.sup.A and R.sub.1.sup.b represents hydrogen or an acyl radical Ac, or in which R.sub.1.sup.a and R.sub.1.sup.b conjointly form a bivalent amino protective group, R.sub.2 denotes hydroxyl or a radical R.sub.2.sup.A which, together with the carbonyl grouping --C(.dbd.0)--, forms a protected carboxyl group, and R.sub.3 represents hydrogen or an organic radical which is linked via a carbon atom to the ring carbon atom, and 1-oxides thereof, as well as salts of such compounds having salt-forming groups, which compounds possess antibiotic properties, processes for the manufacture of such compounds, and also pharmaceutical formulations containing compounds of the formula I with pharmacological properties, and the use thereof, either as antibiotics, preferably in the form of pharmaceutical formulations, or as intermediate products.

    Abstract translation: 本发明涉及式（I）的6-氨基-2-青霉烯-3-羧酸化合物，其中R 1a表示氢或氨基保护基R 1A和R 1b表示氢或酰基Ac，或其中 R1a和R1b共同形成二价氨基保护基，R2表示羟基或R2A基团，与羰基-C（= O）一起形成保护的羧基，R3表示氢或连接的有机基团 通过碳原子与环碳原子及其1-氧化物，以及具有成盐基团的化合物的盐，该化合物具有抗生素性质，制备这些化合物的方法，以及含有化合物的化合物的药物制剂 具有药理学性质的式I及其用途，优选为药物制剂形式的抗生素或作为中间产物。

    Quaternary 3 -Amido, N-Methylpyridinium Salts as Anti-Inflammatory Agents
    8.
    发明申请
    Quaternary 3 -Amido, N-Methylpyridinium Salts as Anti-Inflammatory Agents 审中-公开
    第四纪3号 - 甲基吡啶鎓盐作为抗炎剂

    公开(公告)号：US20080249140A1

    公开(公告)日：2008-10-09

    申请号：US12094169

    申请日：2006-11-29

    Applicant: Jacques Gosteli

    Inventor： Jacques Gosteli

    IPC: A61K31/44 ,  C07D213/02 ,  A61P29/00

    CPC classification number: C07D213/82

    Abstract: A novel group of anti-inflammatory compounds are salts composed of the anion of a nonsteroidal anti-inflammatory acid drug (NSAID) and the cation N(1)-methylnicotinamide, which both anion and cation moieties alone exhibit anti-inflammatory activity, and which in this combination have advantages over the individual compounds and in comparison to commercial anti-inflammatory products. The compounds are produced in analogy to processes known in the art. They are used for the preparation of new pharmaceutical formulations with anti-inflammatory and analgesic activity. The new pharmaceutical formulations exhibit several advantageous properties over preparations of prior art.

    Abstract translation: 一组抗炎化合物是由非甾体抗炎酸药物（NSAID）的阴离子和阳离子N（1） - 甲基烟酰胺组成的盐，阴离子和阳离子部分单独表现出抗炎活性，其中 在这种组合中，与各种化合物相比具有优势，与商业抗炎产品相比具有优势。 化合物类似于本领域已知的方法制备。 它们用于制备具有抗炎和止痛活性的新药物制剂。 与现有技术的制剂相比，新的药物制剂显示出几种有利的性质。

    Process for producing 2-substituted 5-chlorimidazoles
    9.
    发明授权
    Process for producing 2-substituted 5-chlorimidazoles 失效
    2-取代的5-氯咪唑的制备方法

    公开(公告)号：US5508425A

    公开(公告)日：1996-04-16

    申请号：US317868

    申请日：1994-10-04

    Applicant: Gareth Griffiths ,  Rene Imwinkelried ,  Jacques Gosteli

    Inventor： Gareth Griffiths ,  Rene Imwinkelried ,  Jacques Gosteli

    IPC: C07D233/68 ,  C07D401/06 ,  C07D233/84

    CPC classification number: C07D233/68

    Abstract: The 2-substituted 5-chlorimidazoles of general formula: ##STR1## are new intermediate products for the production of antihypertensive pharmaceutical agents or of herbicidal compounds. A process for the production of these intermediate products as well as a new process for the further reaction of 2-substituted 5-chlorimidazoles of general formula I, wherein R.sub.1 is hydrogen, to the 2-substituted 5-chlorimidazole-4-carbaldehydes of general formula: ##STR2##

    Abstract translation: 2-取代的5-氯咪唑，其通式如下：图1是生产抗高血压药剂或除草化合物的新中间产物。 制备这些中间体产物的方法以及通式I的其它R 1为氢的2-取代的5-氯咪唑与2-取代的5-取代的5-氯咪唑-4-碳醛进一步反应的新方法 公式： II

Patent Agency Ranking